UPLOAD Filing
Genprex, Inc.
Date: June 16, 2025 · CIK: 0001595248 · Accession: 0000000000-25-006297
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287962
Letter
Re: Genprex, Inc. Registration Statement on Form S-1 Filed June 11, 2025 File No. 333-287962 Dear Ryan Confer:
June 16, 2025
Ryan Confer President, Chief Executive Officer and Chief Financial Officer Genprex, Inc. 3300 Bee Cave Road #650-227 Austin, TX 78746
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Lloyd Jeglikowski, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 16, 2025 Ryan Confer President, Chief Executive Officer and Chief Financial Officer Genprex, Inc. 3300 Bee Cave Road #650-227 Austin, TX 78746 Re: Genprex, Inc. Registration Statement on Form S-1 Filed June 11, 2025 File No. 333-287962 Dear Ryan Confer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Lloyd Jeglikowski, Esq. </TEXT> </DOCUMENT>